News & Perspective

Nov 09, 2016

Nov 09, 2016
Aedes mosquito

Florida split over genetically modified mosquitoes

In related developments, Florida reported seven new locally acquired Zika cases yesterday and today, one of them in a traveler from out of state.

Oct 27, 2014

Oct 27, 2014

CSL-Novartis deal includes US cell-based flu vaccine plant

The $275 million deal will make the company the second leading player in the $4 billion global flu vaccine market.

May 10, 2013

May 10, 2013

Groups take next H7N9 vaccine step amid questions about summer spread

(CIDRAP News) – The steep decline in H7N9 cases in China has influenza experts wondering if poultry market closures have slowed the disease or if the new virus is showing a summerlike decline that other avian flu viruses show, according to the latest assessments today.

Oct 18, 2011

Oct 18, 2011

Anthrax countermeasures better than in 2001, but work remains

(CIDRAP News) – If someone tried to kill Americans with Bacillus anthracis spores today, the nation would have a better medical tool chest for treating the sick and those potentially exposed than it had 10 years ago, when the anthrax letter attacks killed five people, but anthrax defenses are still a work in progress.

Oct 06, 2010

Oct 06, 2010

Trial answers some, not all, questions on cell-based flu vaccines

(CIDRAP News) – A new report says that a cell culture derived influenza vaccine and a conventional egg-based vaccine both proved effective in a large international clinical trial, offering support for those who contend that cell-based vaccines should become an important part of flu vaccine supplies in coming years.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»